A Study to Evaluate the Conformis iTotal Identity Knee Replacement System

Osteoarthritis, Knee Clinical Trial

Official title:

A Prospective, Multicenter Study to Evaluate the Conformis iTotal Identity Knee Replacement System

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT04667559
• Other study ID #: 20-001
• Status: Terminated
• Start date: October 12, 2020
• Est. completion date: December 14, 2022

Study information

• Verified date: October 2023
• Source: Restor3D
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This is a prospective multicenter study located in the United States. Subjects will be implanted with an iTotal Identity Knee Replacement System and followed for 10 years post implantation.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 22
• Est. completion date: December 14, 2022
• Est. primary completion date: December 14, 2022
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Clinical condition included in the approved Indications For Use for the iTotal Identity CR KRS
• Osteoarthritis, as confirmed by the investigator's assessment of disease status at screening visit that warrants a TKR procedure. Disease status is assessed by Clinical and Radiographic assessment.
• Willingness to participate in the clinical study, to give informed consent, and to attend all follow-up visits
• > 18 years of age with complete development of musculoskeletal structures

Exclusion Criteria:

• Simultaneous bilateral procedure required
• BMI > 40
• Active malignancy (defined as a history of any invasive malignancy - except nonmelanoma skin cancer), unless subject has been treated with curative intent and there have been no clinical signs or symptoms of the malignancy for at least 5 years
• Poorly controlled diabetes (defined as HbA1c >7 or Investigator discretion)
• Neuromuscular conditions which prevent subject from participating in study activities
• Active local or systemic infection which precludes TKR procedure
• Immunocompromised in the opinion of the Investigator
• Medically diagnosed fibromyalgia or similar conditions that might impact the subject's ability to differentiate source of pain
• Rheumatoid arthritis or other forms of inflammatory joint disease
• Loss of bone or musculature, osteonecrosis, neuromuscular or vascular compromise in the area of the joint to be operated on, to an extent that the procedure is unjustified
• Diagnosed with or receiving treatment for osteoporosis that is likely to confound results in the opinion of the Investigator
• Other physical disability affecting the hips, spine, or contralateral knee that is likely to confound results in the opinion of the Investigator
• Severe instability due to advanced loss of osteochondral structure
• Prior arthroplasty of the affected knee, including High Tibial Osteotomy (HTO)
• Compromised PCL or collateral ligament
• Severe fixed valgus or varus deformity of >15º
• Extensor lag > 15º
• Fixed flexion contracture = 15º
• Unwilling or unable to comply with study requirements
• Participation in another clinical study which would confound results
• Allergy to any of the implant materials
• Pregnant or planning to become pregnant prior to study TKR procedure (in case of pregnancy after study TKR procedure, eligibility to continue with the protocol will be reviewed)

Related Conditions & MeSH terms

• Osteoarthritis, Knee

Intervention

Device:
• Conformis iTotal Identity Knee Replacement System
The iTotal® Identity KRS is a tri-compartmental semi-constrained knee prosthesis composed of three components: a Femoral Component, a Tibial Component, and a Patellar Component.Using patient imaging, a patient-specific implant is designed that best meets the geometric and anatomic requirements of the specific patient. The treatment allows for the placement of a cemented metallic device designed from the patient's natural bone geometry. This process allows definition of the shape and size of the femoral and tibial components of the implant, as well as the disposable instrumentation.

Locations

Country	Name	City	State
United States	Personalized Orthopedic Research Institute	Boynton Beach	Florida
United States	Tennessee Orthopaedic Alliance	Nashville	Tennessee

Sponsors (1)

Lead Sponsor	Collaborator
Restor3D

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain and function	Measured by 2011 Knee Society Clinical Rating Score (objective knee score 0-125, function score 0-100, satisfaction score 0-40, expectation score 0-15 with higher scores meaning better outcome)	2 years post implantation
Secondary	Revision rate		Post implantation up to 10 years
Secondary	Incidence of major procedure-related and device-related complications, including infection rate		Post implantation up to 10 years
Secondary	Post-operative hip-knee-ankle limb alignment (with 180 degrees being the expected outcome, plus or minus 5 degrees), if long leg x-rays available		Post implantation up to 10 years
Secondary	Number of patients demonstrating radiographic loosening, radiolucency	Review of x-rays to subjectively determine evidence of implant disassociation with bone	Post implantation up to 10 years
Secondary	Length of procedure		Implant procedure from time the patient enters the operating room til time the surgery is complete and patient exits the operating room (up to 6 hours)
Secondary	Length of hospital stay in hours		Time from patient admission to hospital before surgery til discharge from hospital (up to 72 hours)
Secondary	blood loss during surgery		Implant procedure from time the patient enters the operating room til time the surgery is complete and patient exits the operating room (up to 6 hours)
Secondary	blood transfusion rates		Implant procedure from time the patient enters the operating room til time the surgery is complete and patient exits the operating room (up to 6 hours)